18-Jun-2026
One in Three Americans Delay Medical Care Due to Cost, HealthEquity Research Finds
Globe Newswire (Mon, 8-Jun 11:56 AM ET)
HealthEquity Reports First Quarter Ended April 30, 2026 Financial Results; Raises Guidance
Globe Newswire (Thu, 28-May 4:01 PM ET)
HealthEquity Announces First Quarter Earnings Release Date and Investor Conference Schedule
Globe Newswire (Tue, 5-May 4:01 PM ET)
HealthEquity Appoints Sanford Health CEO Bill Gassen to Board of Directors
Globe Newswire (Mon, 30-Mar 8:30 AM ET)
HealthEquity Delivers 29% EPS Growth and Strong HSA Asset Expansion—Adjusted EBITDA Margin Hits 44%
Market Chameleon (Thu, 4-Dec 6:19 AM ET)
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
Healthequity trades on the NASDAQ stock market under the symbol HQY.
As of June 18, 2026, HQY stock price declined to $85.21 with 1,097,886 million shares trading.
HQY has a beta of 0.62, meaning it tends to be less sensitive to market movements. HQY has a correlation of 0.05 to the broad based SPY ETF.
HQY has a market cap of $7.12 billion. This is considered a Mid Cap stock.
Last quarter Healthequity reported $355 million in Revenue and $1.24 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.16.
In the last 3 years, HQY traded as high as $116.65 and as low as $59.02.
The top ETF exchange traded funds that HQY belongs to (by Net Assets): IJH, VTI, VB, IWM, VBK.
HQY has underperformed the market in the last year with a return of -16.5%, while the SPY ETF gained +26.9%. In the last 3 month period, HQY fell short of the market, returning +7.1%, while SPY returned +13.5%. However, in the most recent 2 weeks HQY has outperformed the stock market by returning -1.0%, while SPY returned -1.1%.
HQY support price is $84.14 and resistance is $88.52 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HQY shares will trade within this expected range on the day.